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INTRODUCTION
Preeclampsia is a pregnancy-related hypertensive
disorder which usually occurs after 20 weeks of
gestation. If left untreated, it will progress to
eclampsia.1 Preeclampsia and eclampsia are not
distinct disorders but are the manifestation of the
spectrum of clinical symptoms of the same condi-
tion. The mildest disorder in this continuum is
pregnancy-induced hypertension. In preeclampsia,
hypertension and proteinuria are present, and
when convulsions occur in addition to these signs,
the condition is referred to as eclampsia.2
Hypertension in pregnancy, the majority of
preeclampsia and eclampsia, are the leading causes
of maternal mortality and morbidity in developing
countries.3,4 Preeclampsia and eclampsia are the
major common complication of pregnancy, while
others are bleeding and infection.5 Globally, pre-
Abstract
Objective: To analyze risk factor, both clinical and laboratory find-
ings, associated with maternal mortality from severe preeclampsia
and eclampsia in Atma Jaya Hospital.
Methods: This was a retrospective case control study. All medical
records of maternal death associated with severe preeclampsia and
eclampsia between 1st January 2009 and 31st December 2011 were
obtained and then information about risk factors were collected and
tabulated. Risk factor analyzed were maternal age, gestational age,
parity, coexisting medical illness (hypertension), antenatal examina-
tion status, maternal complications, systolic and diastolic blood pres-
sure at admission, and admission laboratory data.
Results: There were 19 maternal deaths associated with severe
preeclampsia and eclampsia during period of study (Consisted of 6
cases of eclampsia and 13 cases of severe preeclampsia). Maternal
mortality rate for severe preeclampsia and eclampsia were 16.7%
and 33.3% respectively. Multivariate analysis identified the follow-
ing risk factors associated with maternal death: gestation age <32
week, history of hypertension, thrombocyte count < 100.0000/μl, post
partum bleeding, acute pulmonary edema, HELLP syndrome, and
sepsis.
Conclusion: In this study, we found that gestational age, history of
hypertension, and platelet count are the cause of maternal mortality.
Maternal complications associated with maternal mortality are post
partum bleeding, acute pulmonary edema, HELLP syndrome, and
sepsis.
[Indones J Obstet Gynecol 2012; 36-2: 90-4]
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Abstrak
Tujuan: Untuk menganalisis faktor-faktor risiko (klinis dan temuan
laboratorium) yang berhubungan dengan kematian ibu akibat preek-
lampsia berat dan eklampsia di Rumah Sakit Atma Jaya.
Metode: Penelitian ini merupakan studi kasus kontrol. Semua catatan
medis kematian ibu akibat preeklampsia berat dan eklampsia antara
tanggal 1 Januari 2009 dan 31 Desember 2011, diperoleh informasi
tentang faktor risiko kematian kemudian dikumpulkan dan ditabulasi.
Faktor risiko yang dianalisis adalah usia ibu, usia kehamilan, paritas,
riwayat penyakit (hipertensi), status kehamilan, komplikasi ibu,
tekanan darah sistolik dan diastolik saat masuk, dan data hasil labo-
ratorium.
Hasil: Terdapat 19 kasus kematian ibu akibat preeklampsia berat dan
eklampsia selama waktu penelitian, yang terdiri dari 6 kasus eklamp-
sia dan 13 kasus preeklampsia berat. Angka kematian ibu untuk
preeklampsia berat dan eklampsia adalah 16,7% dan 33,3%. Analisis
multivariat menunjukkan faktor-faktor risiko berikut terkait dengan
kematian ibu: usia gestasi <32 minggu, riwayat hipertensi, jumlah
trombosit <100.0000/μl, perdarahan post partum, edema paru akut,
sindrom HELLP, dan sepsis.
Kesimpulan: Dalam penelitian ini, kami menemukan bahwa usia ke-
hamilan, riwayat hipertensi,dan jumlah trombosit merupakan penye-
bab kematian ibu. Komplikasi ibu terkait dengan kematian ibu adalah
perdarahan post partum, edema paru akut, sindrom HELLP, dan sep-
sis.
[Maj Obstet Ginekol Indones 2012; 36-2: 90-4]
Kata kunci: eklampsia, kematian ibu, preeklampsia
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eclampsia and eclampsia account for 10%-15% of
maternal deaths. The majority of deaths in devel-
oping countries result from eclampsia, while in de-
veloped countries, complications of pre-eclampsia
are more often as a cause.6 In the US, preeclampsia
and eclampsia are the third leading cause of ma-
ternal mortality, accounting for 54 of 540 maternal
deaths in 2004, followed by embolism and hemor-
rhage.7 It can also lead to significant fetal morbidity
and mortality, including an increased incidence of
placental abruption, fetal growth restriction, and
preterm delivery. Due to its frequent occurrence
and potential severity, early diagnosis and appro-
priate management are essential.
Maternal mortality due to preeclampsia and
eclampsia are caused by disseminated intravascu-
lar coagulation, acute renal failure, hepatocellular
damage, hepatic rupture, intracerebral hemorrhage,
cardiac arrest, respiratory failure, pulmonary
edema, and hemorrhage after childbirth.8
METHODS
Data were derived from Atma Jaya Hospital. The
data comprised of all patients with severe pree-
clampsia and eclampsia who were treated at Atma
Jaya Hospital from 1 January 2009 until 31 Decem-
ber 2011.
This study was a case-control study, comparing
the clinical parameters and laboratory between se-
vere preeclampsia and eclampsia patients ended
with death, and severe preeclampsia and eclampsia
patients which did not end with death. The cases
were all patients with severe preeclampsia and
eclampsia who ended up died. Cases where the pa-
tient was already dead upon admittance to hospital
were excluded. Whereas for the control, the sam-
ples taken were severe preeclampsia and eclamp-
sia cases that occurred during the same year, but
did not end with death.
The characteristics of subjects recorded in this
study were age, gestational age, multiple pregnan-
cies, primiparous, history of hypertension, ante-
natal examination, sopor-coma state. Age were
classified into 2 groups, which is less than 35 years
and more than 35 years, tailored to the research
by Mackay and his colleagues which showed that
maternal age over 35 years is associated with in-
creased risk of death.9 Based on gestational age,
the subjects were classified into 2 groups: under
32 weeks and over 32 weeks. Previous studies
mentioned that the gestational age below 32 weeks
is a risk factor for maternal mortality.10 Other risk
factors such as primiparous, history of hyperten-
sion, poor antenatal examination and the state of
coma sopor are risk factors for maternal mortal-
ity.11 In addition to the characteristics, we also as-
sessed the parameters of laboratory results. The
laboratory results were classified into leukocytes,
thrombocytes, SGOT, SGPT, and creatinine. Leuko-
cytes were assessed with 15.000/μl threshold,
platelets 100,000/μl threshold, AST and ALT 150
IU/l threshold, and creatinine 1.5 mg/dl threshold.
Those values were used based on National High
Blood Pressure Education Program report that said
the value was associated with maternal mortal-
ity.12
Researches data obtained were recorded in a
special form provided, then tabulated and analyzed
with SPSS (Statistic Package for Social Science)
computer software version 16 for Windows. Bi-
variate relationship between the studied risk fac-
tors and maternal mortality were tested using Chi
square test for categorical data and Student t test
for numerical data, as well as by calculating odd
ratios and 95% confidence interval.
RESULTS
According to the data recorded between the years
2009-2011 in Atma Jaya Hospital, there were 1236
labor. As a whole, there were 96 recorded cases
(7.8%) of preeclampsia and eclampsia, in which
there were 18 cases (1.5%) of eclampsia. Hence,
on average year there are 24 severe preeclampsia
patients and 6 eclampsia patients. Between the
years of 2009-2011 there were 32 recorded cases
of maternal mortality and 19 (59.4%) of them oc-
curred in patients with severe preeclampsia and
eclampsia.
Between the years 2009-2011 there were 19
maternal deaths associated with severe preeclamp-
sia or eclampsia. 6 cases (31.6%) were eclampsia,
and the rest were cases of severe preeclampsia, so
the percentage of deaths due to eclampsia was
33.3% and for severe preeclampsia was 16.7%.
 47.4% of patients were referred by an obstetri-
cian and gynecologist, while the rest were referred
by midwife, general practitioner or came without
referral. Age of the patients who died ranged be-
tween 20 years to 39 years, the average was 28.2
years. A total of 6 patients (31.6%) were primi-
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parous. 26,3% patients were doing antenatal ex-
amination during pregnancy and 47.4% of whom
were examined by midwife.
In the case, 11 patients (57.9%) were not in la-
bor yet. In 5 of 6 cases of eclampsia (83.3%), sei-
zures occurred before or during birth. Most of the
seizures occurred before the patient entered the
Atma Jaya Hospital, but there was 1 case in which
the first seizure occurred at Atma Jaya Hospital. In
4 of 6 cases of eclampsia (66.6%) patients were
admitted to hospital  with sopor or coma level of
consciousness, while the other two were in a cir-
culatory shock condition. The major causes of death
were bleeding and respiratory failure caused by
pulmonary edema, sepsis, and HELLP syndrome.
 Patients with severe preeclampsia and eclamp-
sia in Atma Jaya Hospital died after averagely 5.3
days of treatment. A total 5 (26.3%) patients died
within the first 24 hours and 31.6% of patients
died after undergoing treatment for 7 days. The pa-
tient being treated the longest was the one who
had severe preeclampsia with pulmonary edema.
The patient were treated up to 18 days before fi-
nally died from septic shock. About 57.9% died in
the intensive care unit, while the rest died in the
delivery room or on the operating table.
As a control, we obtained 77 patients consisting
of 12 eclampsia patients and 65 severe pre-eclamp-
sia patients. Clinical comparison between case pa-
tients and control patients can be seen in Table 1.
Table 1. Patient characteristics of case patients and con-
trol patients
Characteristics
Case (n=19) Control (n=77)
pSD (%) SD (%)
Mean age (year) 28.2  6.5 29.6  7.50 0.439
Age >35 year  3 15.80 19 24.70 0.311
Gestation age <32 weeks  9 47.40  5  6.50 0.000*
Multiple Pregnancy  2 10.50  3  3.90 0.256
Primiparous 13 68.40 52 67.50 0.568
History of hypertension 10 52.60 13 16.90 0.002*
Antenatal examination  4 21.10 17 22.10 0.597
A state of sopor-coma  2 10.50  5  6.50 0.420
Systolic 176 mmHg SD=16.7 170.5 mmHg SD=17.8 0.203
Diastolic 110 mmHg SD=14.3 106 mmHg SD=12  0.197
SD=Standard Deviation
*= significant
The patient was examined for blood pressure
measurements at the Atma Jaya Hospital, before
being given anti hypertensives. Anti hypertensive
medication consumed before may affect the value
obtained.
Any patient with a diagnosis of severe pree-
clampsia or eclampsia who entered the Atma Jaya
Hospital was generally had their blood samples
taken directly for laboratory examination. Initial
laboratory data of patients admitted to Atma Jaya
Hospital can be seen in Table 2. For multivariate
analysis, significant laboratory value is classified
into 2 groups (Table 3).
Table 2. Initial laboratory data of patients admitted to
Atma Jaya Hospital
Variable Mean Case SD Mean Control SD p
Proteinuria (semi-
quantitative)
 2.4 10.6  2.3 0.9 0.59
Haemoglobin (gr/dl) 11.5  1.9 11.6 1.6 0.79
Haematokrit (vol%) 36.2  5.9 36.4 3.9 0.79
Leucocyte (/μl) 16.258 4.107 13.982 4.465 0.04*
Thrombocyte (/μl) 197.584 133.624 244.497 90.321 0.07
SGOT (IU/l) 147 170 115 100 0.29
SGPT (IU/l) 124 129 99 94 0.34
Creatinine (mg/dl)  1.3  0.6  1.2 0,5 0.72
SD=Standard Deviation
*= significant
Table 3. Laboratory parameter comparison between case
patients and control patients
Variable
Case Control
p OR CI 95%
n % n %
Leukocyte
> 15.000/μl
<15.000/μl
13
 6
68.40%
31.60%
34
43
44.20%
55.80%
0.075 0.4 0.18-1.07
Thrombocyte
<100.000/μl
>100.000/μl
 8
11
42.10%
57.90%
 8
69
10%
90%
0.003* 3.6 1.74-7.59
SGOT
>150 IU/l
<150 IU/l
11
 8
57.90%
42.10%
34
43
44.20%
55.80%
0.314 0.6 0.28-1.45
SGPT
>150 IU/l
<150 IU/l
 8
11
42.10%
57.90%
31
46
40.30%
59.70%
1 0.9 0.42-2.12
Creatinine
>1,5 mg/dl
<1,5 mg/dl
10
 9
52.60%
47.40%
35
42
45.50%
54.50%
0.616 0.8 0.36-1.78
*=significant
Complications explained here include the com-
plications that had occurred when patients came
in as well as other complications that aroused dur-
ing treatment. These complications may be due to
complications of preeclampsia such as HELLP syn-
drome, pulmonary edema, or other complications
such as post-partum bleeding, magnesium sulfate
intoxication, sepsis, and vagal reflexes. Comparison
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of complications that occured in mothers between
cases and controls can be seen in Table 4.
Table 4. Comparison of maternal complications
Variable Case % Control % p
Post partum bleeding 10/19 52.60% 4/77 5.20% 0.000*
Acute pulmonary edema 11/19 57.90% 7/77 9.10% 0.000*
HELLP syndrome 8/19 42.10% 7/77 9.10% 0.002*
Sepsis 9/19 47.40% 5/77 6.50% 0.000*
*=meaningful
 
DISCUSSION
Although the number of patients who died from
severe preeclampsia was higher than eclampsia pa-
tient, but the death rate of eclampsia is much
higher, reaching to 33.3%, compared with severe
preeclampsia 16.7% (from 2009-2011). This figure
is much higher than compared with developed
countries, where the death rate from eclampsia
reach 0.4%.9
This study was primarily aimed to determine
what factors are associated with the occurrence of
death in patients with severe preeclampsia and
eclampsia. From univariate analysis, factors found
associated with the occurrence of maternal deaths
were gestational age, a history of hypertension,
thrombocyte <100,000/μl. Maternal complications
found related to death are post partum bleeding,
pulmonary edema, HELLP syndrome, and sepsis.
 Age differences between cases and controls
were found not statistically significant. When clas-
sified into 2 groups (less than 35 years and over
or equal to 35 years), there was still no significant
difference found. This is probably caused by the
number of patients with relatively a few cases, so
it did not give significant differences.1
The characteristic based on gestational age was
classified into 2 groups: under 32 weeks and over
32 weeks. Previous studies mentioned that the ges-
tational age below 32 weeks is a risk factor for ma-
ternal mortality.10 The above research shows that
gestational age less than 32 weeks has an impor-
tant role in maternal mortality. Morbidity and mor-
tality number of preeclampsia and eclampsia oc-
curring in preterm pregnancies were occasionally
higher than those in term pregnancies. This fact is
important to note, especially if we’re going to con-
servatively manage patients with severe pre-
eclampsia at less than 32 weeks gestation.
Repeated labor will give a lot of risk to the preg-
nancy. In addition, one theory that predisposes to
severe preeclampsia and eclampsia is the factor of
parity (primigravida). Statistical record shows that
from worldwide incidence, from 5%-8% of all
preeclamptic pregnancies, more than 12% of them
were primigravida.13 Factors affecting the fre-
quency of primigravida preeclampsia are found
more frequently than in multigravida, especially
the young primigravida.14 From our research, it
was found that those two factors do not play an
important role in the deaths of hospital patients in
our study.
A history of chronic hypertension may aggravate
the complications of severe preeclampsia and
eclampsia because sometimes there are also a kid-
ney disorder, heart muscle disorders, as well as a
higher risk of stroke. Early detection and counsel-
ing for pregnant patients with a history of chronic
hypertension is very important.8,11 From the sta-
tistical research conducted by us, it was found that
a history of hypertension had a role in maternal
mortality.
Antenatal examination also seemed unrelated to
risk of death. But the quality of antenatal examina-
tion was not inspected in this study. Some research
suggests mothers not to do antenatal examination,
at risk of experiencing a complicated eclampsia and
death from preeclampsia and eclampsia.15 This find-
ing may reflect a poor quality of antenatal care that
any symptoms or signs of complication of a preg-
nancy are not detected or not handled properly. In
addition, information about the symptoms or signs
of danger in pregnancy, may be not understood by
patients, so in some cases, patients are too late to
seek help from a midwife or a doctor, even if the
symptoms are present long enough to be felt.11
Apart from that, the state of sopor-coma in our
study did not show the causes of death although
the actual state of sopor-coma may aggravate se-
vere preeclampsia and eclampsia.
In this study, we obtained several laboratory pa-
rameters associated with the risk of maternal death,
such as thrombocyte. This is consistent with the inci-
dence of complications of HELLP syndrome in a pa-
tient who died. Approximately 50% of patients with
HELLP syndrome are also accompanied by other
complications such as eclampsia, sepsis, and DIC.
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Leukocyte count in the case group was found to
be significantly higher than in the control group
(16.258 SD 4.107/μl vs 13.982 SD 4.465, p=0.04).
The results are statistically significant but not clini-
cally significant. Higher leukocytes may be caused
by infection or sepsis is more common in the case.
Leukocytes of patients presenting over 15,000 in
the case is 68.4% compared with 44.2% of control.
Other parameters associated with the risk of ma-
ternal death are SGOT, SGPT, and creatinine. In-
crease in SGOT, SGPT, and creatinine showed that
most patients who died had a kidney and liver com-
plications. But in this study, these parameters did
not show significant thing. This is probably caused
by the number of patients with relatively a few
cases, so it did not give significant differences.
In this study, it was found that 10 of 19 patients
who died, or about 52.6%, had bleeding complica-
tions. And it was found that 9 of 19 patients who
died, or about 47.4%, had sepsis complications.
 Acute pulmonary edema was also seen as one
cause of death. Pulmonary edema can occur after
seizures of eclampsia. This can occur due to pneu-
monia from aspiration of gastric contents into the
respiratory tract caused by vomiting during the sei-
zure. Moreover, it can also due to cardiac decom-
pensation experienced by patients, as a result of se-
vere hypertension and excessive fluid administra-
tion.11,16
Apart from clinical factors and obstetric compli-
cations above, the factors of health services also
have a very large role in maternal mortality. These
factors include the difficulty of access to maternal
health services, poor medical care, and inadequate
or unaffordable support facilities. By analyzing
these factors, precautionary measures to reduce
maternal mortality can be carried out.17
CONCLUSION
Factors associated with maternal mortality was ges-
tation age below 32 weeks, with a history of hyper-
tension, laboratory results below 100,000/μl, had
some maternal complications such as post partum
bleeding, acute pulmonary edema, HELLP syndrome,
and sepsis. The goal of this study is to find out the
cause of death of preeclampsia and eclampsia pa-
tients, so mortality can be anticipated and be reduced.
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